Data Executives Talk Gen AI at CDO Magazine’s Executive Boardroom Dinner in Boston

During the 17th annual CDOIQ Symposium in Boston, 40 senior data, analytics and AI executives from CDO Magazine’s Boston community and other Global Editorial Board members gathered for an evening of knowledge sharing and networking on July 18. The highlight was the engaging panel discussion on the timely topic of “Generative AI and Its Impact on the Enterprise.”

The panel featured prominent pharmaceutical executives at the forefront of the data and AI landscape, Raj Nimmagadda, Sanofi Chief Data Officer R&D, Data and Data Sciences; Barbara Latulippe, Takeda Head of Enterprise Data; and Chathuri Daluwatte, AstraZeneca Head of AI Diagnostics, Alexion AstraZeneca Rare Diseases, with moderator Sam Ramachandran, Tiger Analytics Chief Sales Officer.

Click on picture to enlarge.

The discussion fostered a dynamic exchange of perspectives, innovative ideas and leadership challenges. The panel speakers called out these key points:

• “AI needs Data and Data needs AI,” states Nimmagadda. “Generative AI capabilities will automate even more data management tasks and processes.” She emphasizes that, “Organizations need to develop a data strategy that is aligned with business strategy to accelerate the value generation from AI models.”

• Sharing about her experience at Takeda, Latulippe says: “We are accelerating our journey and identifying use cases where we can drive value realization for the business leveraging AI/GenAI to transform our organization. It is built on a strong enterprise data foundation focused on data quality and trust as an enabler for unleashing the power of AI/GenAI.”

• According to Daluwatte: “For life sciences, biology is like an information processing system. Just like mathematics is the modality that describes physics, AI has the potential to be the modality that describes biology. With regulation compliance, life science is in a great place to achieve gains from AI.”

Other points raised during the discussion:

• The arrival of generative AI has also advanced and accelerated data initiatives.

• Other industries can learn from pharmaceutical companies since they already have tools in place for regulation.

• Generative AI has huge potential to disrupt and transform pharmaceutical drug development.

“We are thrilled to have provided a platform for meaningful conversations and connections that will undoubtedly drive advancements within the industry,” says Steve Wanamaker, CEO and Publisher of CDO Magazine. “CDO Magazine remains committed to organizing thought leadership events with our executive communities regionally and around the globe. We want to help empower and elevate the data ecosystem by fostering collaboration among industry data leaders.”

Many thanks to our panelists, participants and sponsors:

Anjali Gupta Reddi, Dow Jones Chief Data Officer; Arjun Mattangote, Fidelity Investments Head of Data Discovery Platform; Barbara Latulippe, Takeda Head of Enterprise Data; Bharat Tripathi, National Grid Global Head of Data Platform, Analytics & Data Engineering; Brent Mahan, Moderna Senior Director of Data & Analytics Enablement; Brian Coogan, Fidelity Investments Vice President & Innovation Leader; Chathuri Daluwatte, Alexion AstraZeneca Rare Disease Head of AI Diagnostics; Christina Sandema-Sombe, Nike Chief Data Steward; Cliona Molony, IDEXX Chief Data Officer & VP of R&D; Clive Sombe, Nike Analytics Manager, Commercial Analytics; Devshree Golecha, TDECU Vice President of Data; Gagan Singh, Tiger Analytics Growth Partner, Insurance & Healthcare; Gokula Mishra, Direct Supply Vice President of Data Science; Ido Biger, Delek US Holdings EVP, Chief Technology & Data Officer; Jacob Hesterman, Ratio Therapeutics Chief Data Officer; Jane Chen, Analog Devices Sr. Director of Growth Analytics, Revenue Strategy & Operations; Jane Urban, Otsuka Pharmaceutical Companies VP, Customer Engagement Operations; Jason Duke, U.S. Fish & Wildlife Service Acting Deputy Associate Chief Information Officer; Jawad Khan, Tufts Medicine Chief Data & Analytics Officer; Kiran Kodali, Sanofi Head of R&D Data Strategy, Governance & Data Foundations; Kishore Aradhya, Stanley Black & Decker Sr. Director, Data & Advanced Analytics; Krishna Valluru, Fidelity Investments VP of Advanced Strategies & Research Tech; Lynne Nowak, Surescripts Chief Data & Analytics Officer; Mahesh Kumar, Tiger Analytics CEO; Nava Cretu-Kessel, National Grid Sr. Director of Customer Data Office & Data Transformation; Prem Swaroop, Dover Corporation Chief Data & Analytics Officer; Raj Nimmagadda, Sanofi Chief Data Officer R&D, Data & Data Sciences; Randall Nufer, Tiger Analytics Director of Banking/Financial Services; Sam Ramachandran, Tiger Analytics Chief Sales Officer; Shahidul Mannan, Bon Secours Mercy Health Chief Data Officer; Sravan Kasarla, Thrivent Chief Data Officer; Tarun Sood, American Century Investments Chief Data Officer; Tom Henry, Schnuck Markets Chief Data & Deputy Chief Information Officer; Venkata Chirravuri, Fidelity Investments Vice President of Enterprise Data Architecture Strategy; and Vishal Puri, Tiger Analytics Tech Partner, Data & AI Engineering.